Shannon 2010.
Study name | Fish oil and green tea extract in preventing prostate cancer in patients who are at risk for developing prostate cancer ClinicalTrial ID: Shannon 2010 |
Methods | Randomised, double‐blind, placebo‐controlled study |
Participants | Men at high risk of prostate cancer Participants are stratified according to age (< 65 vs ≥ 65) |
Interventions | Intervention group A: GTE polyphenols (75%) and EGCG (at least 30% = 300 mg) per 1000 mg capsule (2 capsules/d) Intervention group B: fish oil capsule per 1000 mg with ethyl esters of eicosapentaenoic acid (20:5n‐3) and docosahexanoic acid (3 capsules/d) Intervention group C: A+B Control group: placebo, olive oil capsule 2/3 times/d Duration: 12 weeks |
Outcomes | Primary outcomes Fatty acid synthase expression by immunohistochemistry at pre‐ and post‐intervention (FAS Summary Score) Cell proliferation by Ki67‐immunohistochemistry at pre‐ and post‐intervention Incidence of prostate cancer |
Starting date | July 2005 |
Contact information | Jackie Shannon, Principal Investigator, OHSU Knight Cancer Institute |
Notes | According to 2010 abstract 67 men completed the study, 4 were enrolled. Anticipated sample size 120 men, or 30 men/group |
EGCG: epigallocatechin‐3‐gallate; ESCC: (o)esophageal squamous cell carcinoma; FAS: fatty acid synthase; GTE: green tea extract; RCT: randomised controlled trial